Orchestra BioMed Holdings, Inc.
OBIONASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $356.71M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.46$6.50
- Volume (live)
- -
- Avg. volume (3M)
- 347.90K
Orchestra BioMed Holdings (OBIO) Stock Price & Financial Analysis
Orchestra BioMed Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.39 - $5.66 |
|---|---|
| 52-Week High | $6.50 |
| 52-Week Low | $3.46 |
| Open | $5.46 |
| Volume (last close) | 262.01K |
| Average Volume (3M) | 347.90K |
| Revenue (TTM) | 31.98M |
|---|---|
| Net Income (TTM) | -59.03M |
| Free Cash Flow (TTM) | -59.10M |
| EPS (TTM) | −$1.03 |
| Profit Margin | -184.60% |
| Operating Margin | -181.36% |
| Return on Equity (ROE) | -200.64% |
| Debt to Equity | 2.41 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 356.71M |
|---|---|
| Shares Outstanding | 63.81M |
| Price to Sales (P/S) | 11.16 |
| Price to Book (P/B) | 12.12 |
| EV/EBITDA | -7.06 |
| 50-Day MA | $5.56 |
|---|---|
| 200-Day MA | $4.49 |
| 1-Year Change | +43.95% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Orchestra BioMed Holdings at a Glance
As of the Oct 23, 2026 close, Orchestra BioMed Holdings (OBIO) has a market capitalization of $356.71M. The stock trades at 11.2× sales. Over the trailing twelve months it lost $59.03M on revenue of $31.98M and burned $59.10M of free cash flow. Revenue grew 1346.9% year over year.
As of its latest reported balance sheet, it holds $20.47M in cash and securities against $70.76M of debt, a net debt position of $50.29M.
Orchestra BioMed Holdings does not currently pay a dividend.
The share price is up 43.9% over the past year. At $5.59 (the Oct 23, 2026 close) it sits within its 52-week range of $3.46 to $6.50, above its 200-day moving average of $4.49.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $11.60, 107.5% above the Oct 23, 2026 close.
Frequently Asked Questions About Orchestra BioMed Holdings
What is the current stock price for OBIO?
As of the Oct 23, 2026 close, OBIO stock trades at $5.59. The 52-week range is $3.46–$6.50, with a day range of $5.39–$5.66.
What is the P/E ratio for OBIO?
The P/E ratio (Price-to-Earnings) for OBIO is shown in the Key Statistics section. This valuation metric helps compare Orchestra BioMed Holdings, Inc. to industry peers.
Does OBIO pay dividends?
Orchestra BioMed Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for OBIO?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for OBIO is Buy. The average 12-month price target is $11.60, a 107.5% upside from the Oct 23, 2026 close of $5.59.
What is the market cap of OBIO?
As of the Oct 23, 2026 close, Orchestra BioMed Holdings's market capitalization is $356.7M, classifying it as a small-cap company. Orchestra BioMed Holdings operates in the Healthcare sector within the Biotechnology industry.